Capricor Therapeutics (CAPR) Total Liabilities (2010 - 2026)
Capricor Therapeutics (CAPR) posted quarterly Total Liabilities of $47.6 million for Q1 2026, up 82.16% year-over-year from $26.1 million in Q1 2025, and down 5.14% quarter-over-quarter from $50.2 million in Q4 2025.
Capricor Therapeutics (CAPR) Total Liabilities (2010 - 2026) Analysis & Trends
Capricor Therapeutics' Total Liabilities history runs 17 years deep, the most recent figure standing at $47.6 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 82.16% year-over-year to $47.6 million; the TTM figure through Mar 2026 stood at $47.6 million (up 82.16% YoY), while the FY2025 annual figure was $50.2 million, up 100.48% from the prior year.
- Total Liabilities for Q1 2026 stood at $47.6 million, down from $50.2 million in the prior quarter.
- The five-year high for Total Liabilities was $50.2 million in Q4 2025, with the low at $24.7 million in Q3 2024.
- The 5-year median for Total Liabilities is $38.5 million (2022), against an average of $36.8 million.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities surged 504.94% in 2022, then tumbled 38.14% in 2024.
- Capricor Therapeutics' Total Liabilities stood at $38.3 million in 2022, then fell by 5.68% to $36.1 million in 2023, then tumbled by 30.76% to $25.0 million in 2024, then surged by 100.48% to $50.2 million in 2025, then slipped by 5.14% to $47.6 million in 2026.
- Business Quant data shows CAPR's Total Liabilities at $47.6 million in Q1 2026, $50.2 million in Q4 2025, and $42.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Capricor Therapeutics | 383.47 Mn | 383.47 Mn | - | 47.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.58 Mn |
| Dec 31, 2025 | 50.16 Mn |
| Sep 30, 2025 | 42.57 Mn |
| Jun 30, 2025 | 28.59 Mn |
| Mar 31, 2025 | 26.12 Mn |
| Dec 31, 2024 | 25.02 Mn |
| Sep 30, 2024 | 24.69 Mn |
| Jun 30, 2024 | 26.78 Mn |
| Mar 31, 2024 | 31.01 Mn |
| Dec 31, 2023 | 36.13 Mn |
| Sep 30, 2023 | 38.94 Mn |
| Jun 30, 2023 | 43.28 Mn |
| Mar 31, 2023 | 47.66 Mn |
| Dec 31, 2022 | 38.31 Mn |
| Sep 30, 2022 | 38.50 Mn |
| Jun 30, 2022 | 39.34 Mn |
| Mar 31, 2022 | 40.28 Mn |
| Dec 31, 2021 | 9.96 Mn |
| Sep 30, 2021 | 6.36 Mn |
| Jun 30, 2021 | 6.55 Mn |